A new survey reveals the most important elements for a successful partnership between pharma and clinical research organisations
Featuring: The UK election and Pharma - Brexit and the EMA's relocation - The future of the Pharma-CRO relationship
Post-election jitters have struck pharma after a surprise result for the UK. With Brexit on the horizon and a minority government in charge, has the industry’s optimism been dashed?
With Brexit negotiations beginning, Catalyst Corporate Finance’s Tom Cowap argues that Britain's divorce from the EU could actually give a major boost to the UK’s pharma sector
Wearables are here to stay – and pharma shouldn't ignore this golden opportunity
The US Food and Drug Administration has approved Pfizer’s Besponsa, the first and only CD22-directed antibody-drug conjugate indicated to treat relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL).
18th August 2017
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved the switch of Dovonex Psoriasis Ointment from a prescription-only drug to one available in pharmacies
18th August 2017
AstraZeneca and Merck & Co’s Lynparza will be available to a wider range of patients in the US after regulators expanded the PARP inhibitor’s list of approved uses.
18th August 2017
The Department of Health has announced £5 million of funding for a new obesity policy research unit at University College London, alongside plans to cut calories in some foods to reign in the rising trend of childhood obesity.
18th August 2017
The number of people dying from chronic obstructive pulmonary disease has climbed nearly 12 percent over a 15-year period, an analysis for the Global Burden of Disease Study 2015 has found.
17th August 2017
Joseph B. Laudano, vice president, medical affairs strategy for Medmeme, takes a look at advances in data mining and metrics analysis
In a world of increasingly complex pharma supply chains, technology is playing a growing role in helping smooth the relationship between businesses and their suppliers
A detailed look at the ongoing patent case for Pfizer’s pain drug and what the potentially-landmark ruling could mean for the industry
With Brexit negotiations beginning, Catalyst Corporate Finance’s Tom Cowap argues that Britain's divorce from the EU could actually give a major boost to the UK’s pharma sector
Post-election jitters have struck pharma after a surprise result for the UK. With Brexit on the horizon and a minority government in charge, has the industry’s optimism been dashed?
What does the EMA’s move from London mean for the competitiveness of the UK pharmaceutical industry?
How the recent UK election could affect the NHS
Sue Thomas, Paul Midgley and Steve How, of Wilmington Healthcare, explain how pharma can work with the NHS to transform services
Improving the care of diabetes patients at City Hospitals Sunderland - a joint working initiative with Lilly
Engaging digital while retaining a human touch
Sanofi’s general manager for the UK and Ireland Hugo Fry on leading a company through transitional times
Richard Baderin, head of commercial enterprises at Accretio, on making the most of your resources
Across all industries, people are changing the ways they engage with products, services, and brands. View more...
Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW
